Both in Biotechnology
Protalix BioTherapeutics vs Artiva Biotherapeutics
Over the past year PLX returned +7.1% and ARTV returned +11.0%; their daily moves had a correlation of 0.12.
PLX +7.1% ARTV +11.0%Growth of $1, one year, split-adjusted
| Metric | PLX | ARTV |
|---|---|---|
| Price | $2.56 | $4.19 |
| Market cap | $206.3M | $204.6M |
| Today | −1.16% | −0.12% |
| 1 month | −5.5% | −38.7% |
| 6 months | +20.2% | −62.9% |
| Year to date | +42.2% | −2.4% |
| 1 year | +13.3% | +6.2% |
| Revenue growth (YoY) | +27.1% | — |
| Gross margin | 61.0% | — |
| Net margin | 19.0% | — |
| P/E (TTM) | 10.9× | — |
| Price / sales | 2.6× | — |
| Net cash | $40.7M | $349.4M |
| Dividend yield | — | — |
| Volatility (60d) | 44.7% | 93.2% |
| Short % of float | 4.7% | 20.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).